CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0001 (16.67%)
Nov 4, 2025, 4:00 PM EST
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $263.62 thousand as of November 5, 2025. Its market cap has increased by 16.07% in one year.
Market Cap
263.62K
Enterprise Value
1.59M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has increased from 238.06K to 263.62K, an increase of 10.74%. That is a compound annual growth rate of 0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 263.62K | 14.51% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | 28.16M | 71.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |